Skip to content

BiocSol: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

BiocSol

BE 1003.683.546
NACE 72.101, Research and development on biotechnology
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€612,486
2024 · -€347,534-€264,952
Equity
€4.3m
2024 · €3.6m+€743,546
Cash
€1.2m
2024 · €3.2m-€2.0m
Balance sheet total
€5.8m
2024 · €4.3m+€1.4m

Largest movements

2024 to 2025
Assets
  • Cash -€2.0m

    down €2.0m (-61.4%), from €3.2m to €1.2m

    mainly Investment in fixed assets (net) (-€2.0m) and Receivables within one year (-€1.0m)

  • Intangible fixed assets +€1.4m

    up €1.4m (+149.0%), from €913,334 to €2.3m

  • Receivables within one year +€1.0m

    up €1.0m (+519.2%), from €193,557 to €1.2m

    of which Other amounts receivable: +€909,406

  • Current investments +€500,000

    new in 2025: €500,000

  • Tangible fixed assets +€280,615

    up €280,615 (+1604.5%), from €17,489 to €298,104

    of which Plant, machinery and equipment: +€236,716

Equity and liabilities
  • Investment grants +€906,014

    new in 2025: €906,014

  • Other debts +€874,288

    new in 2025: €874,288

  • Debts after one year -€718,391

    no longer reported in 2025 (was €718,391)

  • Profit (loss) carried forward -€612,486

    down €612,486 (-176.2%), from -€347,534 to -€960,021

  • Contributions +€450,018

    up €450,018 (+11.4%), from €4.0m to €4.4m

Income statement
  • Purchases and services +€1.7m

    new in 2025: €1.7m

  • Staff costs +€368,643

    new in 2025: €368,643

  • Depreciation +€328,813

    up €328,813 (+842.6%), from €39,022 to €367,835

  • Gross operating margin +€313,489

    up €313,489, from -€284,938 to €28,551

  • Financial income +€97,758

    new in 2025: €97,758

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€347,534
Gross operating margin +€313,489
Staff costs -€368,643
Depreciation -€328,813
Other operating charges -€997
Financial income +€97,758
Financial charges +€16,528
Taxes +€5,727
Result 2025 -€612,486

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€89,253
Investment -€2.5m
Financing +€637,641
Cash 2024 €3.2m
Net result for the year -€612,486
Depreciation +€367,835
Receivables within one year -€1.0m
Deferred charges and accrued income -€242,654
Trade debts +€380,213
Tax, wage and social debts +€148,513
Other debts +€874,288
Investment in fixed assets (net) -€2.0m
Current investments -€500,000
Debts after one year -€718,391
Contributions, distributions and other +€1.4m
Cash 2025 €1.2m
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €4,326,793 €5,754,961 +€1.4m +33.0%
Fixed assets 21/28 €931,063 €2,572,553 +€1.6m +176.3%
Intangible fixed assets 21 €913,334 €2,274,448 +€1.4m +149.0%
Tangible fixed assets 22/27 €17,489 €298,104 +€280,615 +1604.5%
Plant, machinery and equipment 23 €10,484 €247,199 +€236,716 +2258.0%
Furniture and vehicles 24 €7,006 €13,754 +€6,749 +96.3%
Other tangible fixed assets 26 - €37,151 +€37,151
Financial fixed assets 28 €240 €0 -€240 -100.0%
Current assets 29/58 €3,395,730 €3,182,408 -€213,321 -6.3%
Amounts receivable within one year 40/41 €193,557 €1,198,519 +€1.0m +519.2%
Trade receivables 40 - €95,556 +€95,556
Other amounts receivable 41 €193,557 €1,102,963 +€909,406 +469.8%
Current investments 50/53 - €500,000 +€500,000
Cash at bank and in hand 54/58 €3,193,683 €1,232,746 -€2.0m -61.4%
Deferred charges and accrued income 490/1 €8,490 €251,143 +€242,654 +2858.2%
Total equity and liabilities 10/49 €4,326,793 €5,754,961 +€1.4m +33.0%
Equity 10/15 €3,604,689 €4,348,235 +€743,546 +20.6%
Contributions 10/11 €3,952,223 €4,402,241 +€450,018 +11.4%
Profit (loss) carried forward 14 -€347,534 -€960,021 -€612,486 -176.2%
Investment grants 15 - €906,014 +€906,014
Amounts payable 17/49 €722,104 €1,406,726 +€684,622 +94.8%
Amounts payable after more than one year 17 €718,391 - -€718,391
Financial debts 170/4 €718,391 - -€718,391
Amounts payable within one year 42/48 €3,713 €1,406,726 +€1.4m +37787.9%
Current portion of amounts payable after more than one year 42 - €0 =
Trade debts 44 €3,713 €383,926 +€380,213 +10240.4%
Suppliers 440/4 €3,713 €383,926 +€380,213 +10240.4%
Taxes, remuneration and social security 45 - €148,513 +€148,513
Taxes 450/3 - €12,496 +€12,496
Remuneration and social security 454/9 - €136,017 +€136,017
Other amounts payable 47/48 - €874,288 +€874,288
Goods, raw materials, services and sundry goods 60/61 - €1,739,086 +€1.7m
Remuneration, social security and pensions 62 - €368,643 +€368,643
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €39,022 €367,835 +€328,813 +842.6%
Other operating charges 640/8 €803 €1,801 +€997 +124.2%
Gross operating margin 9900 -€284,938 €28,551 +€313,489
Operating profit (loss) 9901 -€324,763 -€709,729 -€384,965 -118.5%
Financial income 75/76B - €97,758 +€97,758
Recurring financial income 75 - €97,758 +€97,758
Financial charges 65/66B €22,771 €6,243 -€16,528 -72.6%
Recurring financial charges 65 €22,771 €6,243 -€16,528 -72.6%
Profit (loss) for the period before taxes 9903 -€347,534 -€618,213 -€270,679 -77.9%
Income taxes 67/77 - -€5,727 -€5,727
Profit (loss) for the period 9904 -€347,534 -€612,486 -€264,952 -76.2%
Profit (loss) for the period to be appropriated 9905 -€347,534 -€612,486 -€264,952 -76.2%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 October 2026 via checked.be.